Rena Brand, MD
NPI 1538168935 · Specialist · New York, NY
Enrolled with Medicare as Practitioner - Dermatology · source: CMS PECOS Public Provider Enrollment (2026.04.01)
Rena Brand, MD is a Specialist provider in New York, NY (NPI 1538168935).
Provider details
- NPI number
- 1538168935
- Entity type
- Individual
- Primary specialty
- SpecialistOther Service Providers
- Credential
- MD
- Sex
- Female
- Sole proprietor
- No
Specialties & taxonomies
Other Service Providers
Profile Score
A profile completeness & documented-activity index — NOT a quality, outcomes, or patient-satisfaction rating.
- Registry tenure25% of score
20 yrs in NPPES registry
- Profile completeness25% of score
83% of core fields populated
- Practice footprint15% of score
1 documented practice location
- Medicare service volume (vs. specialty peers)25% of score
4,436 Medicare services, 2024 (ranked within specialty)
- Open Payments transparency10% of score
Has Open Payments disclosures (2024)
Medicare volume is ranked against active providers in the same specialty. Signals a provider has no public data for (e.g. Medicare claims) are left out of the score entirely — never counted as zero — so providers without that data are not penalized. See the full formula and weights in our .
What this provider does (Medicare)
Based on Medicare fee-for-service claims, 2024; not all care is captured.
| Service (HCPCS) | Medicare services | Typical Medicare-allowed (2024) |
|---|---|---|
| Established Patient Office Or Other Outpatient Visit With Moderate Level of Decision Making, If Using Time, 30 Minutes Or More99214 | 1,221 | $142 |
| Established Patient Office Or Other Outpatient Visit With Low Level OD Decision Making, If Using Time, 20 Minutes Or More99213 | 950 | $101 |
| Biopsy of Related Skin Growth, First Growth11102 | 673 | $113 |
| Destruction of Precancer Skin Growth, 2-14 Growths17003 | 572 | $8 |
| Destruction of Precancer Skin Growth, 1 Growth17000 | 407 | $74 |
| Biopsy of Related Skin Growth, Each Additional Growth |
What this provider prescribes (Medicare Part D)
Top drugs by Medicare Part D claim volume, 2024 · 22 distinct drugs on file.
| Drug | Part D claims (2024) | Beneficiaries |
|---|---|---|
| Ketoconazole | 691 | 372 |
| Metronidazole | 383 | 226 |
| Mupirocin | 360 | 283 |
| Triamcinolone Acetonide | 317 | 216 |
| Hydrocortisone | 208 | 112 |
| Fluocinonide | 183 | 116 |
| Clobetasol Propionate | 79 | 45 |
| Clindamycin Phosphate | 71 | 34 |
Transparency — industry payments
Based on CMS Open Payments, 2024; not all care is captured.
$82 across 3 records (Open Payments 2024)
Open Payments discloses payments and transfers of value (meals, travel, consulting, research, royalties) from drug and device makers to providers. This is a transparency signal, not a verdict — such payments are legal and common, and their presence is neither an endorsement nor a criticism. Source: CMS Open Payments, program year 2024.
Practice location
Mailing address
Registry dates
- Enumerated
- 2005-07-18
- Last updated
- 2015-12-22
Frequently asked questions
- What is Rena Brand's NPI number?
- Rena Brand's National Provider Identifier (NPI) is 1538168935, a unique 10-digit ID issued by CMS for use in standard healthcare transactions.
- What is Rena Brand's specialty?
- Rena Brand is listed in the NPPES registry with a primary specialty of Specialist (Other Service Providers).
- Where is Rena Brand located?
- Rena Brand's practice location on file with NPPES is 345 E 37th St, New York, NY 10016-3256.
- What is Rena Brand's phone number?
- The practice phone number listed in the NPPES registry for Rena Brand is (212) 532-5355.
- Does Rena Brand accept Medicare?
- Rena Brand is approved to bill Medicare according to CMS PECOS enrollment data (2026.04.01). Confirm current participation with the provider before scheduling.
- Is Rena Brand's NPI active?
- Yes — Rena Brand's NPI (1538168935) is active in the NPPES registry as of the last update on 2015-12-22.
Source: CMS NPPES Data Dissemination (June 2026). NPI Central is not affiliated with CMS. Data is provided as-is from the public registry.